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Abstract
Background/Aims: Recently the European Society of Gas-
trointestinal Endoscopy delivered guidelines on the preven-
tion of post-endoscopic retrograde cholangiopancreatogra-
phy pancreatitis (PEP) and on the papillary cannulation and 
sphincterotomy techniques at endoscopic retrograde chol-
angiopancreatography (ERCP). There are no data concern-
ing current practices in Portugal. The aim of this study was 
to capture practice patterns of Portuguese pancreaticobili-
ary endoscopists with special interest in the prevention of 
PEP and cannulation techniques. Methods: A written survey 
was distributed to all pancreaticobiliary endoscopists at-
tending the first Portuguese meeting dedicated to ERCP in 
November 2016. The main outcome measures were: tech-
nique used for standard biliary cannulation, use of nonste-
roidal anti-inflammatory drugs (NSAIDs) in PEP, attempting 
prophylactic pancreatic stenting after using pancreatic 
guidewire (PGW)-assisted biliary cannulation in patients 
where biliary cannulation was difficult, and use of precut as 
the first rescue technique when biliary cannulation was dif-
ficult. Results: Completed surveys were collected from 28 of 
the 32 pancreatobiliary endoscopists attending the meeting 
(answer rate 87.5%). Biliary cannulation was performed us-
ing a guidewire access technique by the majority (77%), usu-
ally with a sphincterotome. When cannulation was unsuc-
cessful, precut was the first choice for 70%. NSAIDs were ad-
ministered routinely for PEP by only 54%; PGW-assisted 
biliary cannulation was the first choice after failed standard 
cannulation for a minority of them, and only 27% reported 
to routinely attempt insertion of a pancreatic stent. High-
volume endoscopists (> 150/year) tended to use NSAIDs and 
to insert a stent in PGW-assisted cannulation less often than 
low-volume-endoscopists (50 vs. 83.3%, p < 0.01, and 40 vs. 
100%, p < 0.01, respectively). Precut was started without pri-
or formal training by more than half of the endoscopists. 
Conclusions: There is a pronounced discrepancy between 
evidence-based guidelines and current clinical practice. This 
discrepancy is more pronounced in PEP prophylaxis, espe-
cially among high-volume endoscopists. Some advanced 
techniques in ERCP are initiated unsupervised, without any 
previous formal training. Key Message: There is a significant 
gap between guidelines and routine clinical practice.
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Resumo
Introdução/objetivos: Recentemente a Sociedade Eu- 
ropeia de Endoscopia Digestiva (SEED) publicou reco-
mendações sobre a prevenção de pancreatite pós-CPRE 
(PPC) e canulação biliar e técnicas de esfincterotomia na 
CPRE. Não existe informação acerca da prática corrente da 
CPRE em Portugal, em especial na prevenção da PEP e das 
técnicas de canulação usadas. Métodos: Questionário es-
crito distribuído a todos os executantes de CPRE presen-
tes numa reunião nacional. As análises principais preten-
didas foram: técnicas usadas para a canulação biliar ini-
cial; uso de AINEs na PPC, tentativa de colocação de 
próteses pancreáticas após recurso a canulação biliar 
difícil assistida por fio-guia pancreático; recurso ao pré-
corte e infundibulotomia como técnica de recurso em 
canulações biliares difíceis. Resultados: Foram recolhidos 
28 questionários, num total de 32 especialistas em CPRE 
autónomos e em actividade presentes na reunião (87.5% 
de taxa de resposta). A canulação biliar inicial é obtida 
com recurso a canulação assistida por fio-guia em 77% 
dos inquiridos, habitualmente usando um esfincteróto-
mo. A técnica de recurso mais utilizada (70%) é o pré-
corte, maioritariamente na forma de infundibulotomia. A 
utilização rotineira de AINEs é feita apenas por 27% dos 
inquiridos. A canulação biliar assistida por fio-guia pan-
creática (FGP) é a primeira opção numa minoria e apenas 
27% tentam, rotineiramente, colocar prótese pancreática 
(PP) após esta manobra. Os endoscopistas com maior vo-
lume (> 150/ano) tendem a usar menos frequentemente 
os AINEs e a inserir uma PP na canulação assistida por FGP 
(50 vs. 83,3%, p < 0.01 respetivamente). O pré-corte é ini-
ciado sem supervisão e sem treino especial por mais de 
metade dos endoscopistas. Conclusões: Existe clara dis-
crepância entre as recomendações da SEED e a prática 
corrente em Portugal. Esta discrepância é mais pronun-
ciada na profilaxia da PPC, especialmente em endoscopis-
tas de maior volume. Algumas técnicas avançadas (pré-
corte) são iniciadas sem supervisão e sem treino prévio. 
Mensagem chave: Existe clara discrepância entre as reco-
mendações internacionais e a prática clínica diária.
© 2018 Sociedade Portuguesa de Gastrenterologia 
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Introduction
During the last decades, endoscopic retrograde chol-
angiopancreatography (ERCP) has become the standard 
of care for the treatment of many pancreaticobiliary dis-
eases [1–3]. However, ERCP is a challenging technique 
with a slow learning curve and is associated with com-
plications, some of them life-threatening [4–6]. Post-
ERCP pancreatitis (PEP) is the most common and seri-
ous complication after ERCP [7]. A systematic survey of 
prospective studies including 16,885 unselected patients 
reported an incidence of PEP of approximately 3.5%. Se-
vere pancreatitis was found in 11% of the cases, and 
death occurred in 3% of PEP cases [8]. Therefore, many 
attempts to reduce the rate of this complication have 
been pursued. Prophylactic pancreatic stenting and 
pharmacologic intervention, namely the use of rectal ad-
ministration of 100 mg of diclofenac or indomethacin 
immediately before or after ERCP, have been success-
fully used in reducing the incidence of PEP, particularly 
in high-risk patients [9–12]. Furthermore, the success of 
biliary cannulation is influenced by patient factors 
(anatomy) and experience of the endoscopist [7, 13–15]. 
A harder challenge to access the desired duct often cre-
ates the need for more papillary cannulation attempts or 
rescue strategies. In the last years, papillary cannulation 
attempts have been shown to be an independent predic-
tor of PEP [7, 13–15]. Therefore, the type and number 
of attempts, the strategy of cannulation (contrast- or 
guidewire-assisted), and the type of rescue technique 
(precut) used are all associated with PEP. Recently the 
European Society of Gastrointestinal Endoscopy (ESGE) 
delivered guidelines on the prevention of PEP and on 
the papillary cannulation and sphincterotomy tech-
niques at ERCP [7, 13].
Previous surveys conducted elsewhere [16, 17] have 
shown that despite robust clinical evidence and published 
guidelines, most ERCP practitioners do not follow the 
proposed guidelines. Little is known about the situation 
in Portugal. Therefore, and in order to assess the current 
practices in Portugal, we performed a survey in a large 
audience of Portuguese pancreaticobiliary endoscopists. 
The aim of this study was to evaluate the preferences and 
practice patterns of our endoscopists in the prevention of 
PEP as well as the preferred strategies in standard and dif-
ficult biliary cannulation. Furthermore, we aimed to 
characterize Portuguese pancreaticobiliary endoscopists 
and their current practices.
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Methods
This was a cross-sectional study using a written survey.
Study Population and Setting
All of the Portuguese pancreaticobiliary endoscopists attend-
ing the first Portuguese meeting dedicated to ERCP were invited 
to participate in a written survey. This 2-day course was held at the 
School of Medicine of the University of Minho, Braga during the 
last weekend of November 2016. There were 150 participants in 
the course, including 32 (80%) of the 40 Portuguese credentialed 
biliary endoscopists who perform ERCP in an autonomous envi-
ronment. More than 90% of the chiefs of the national ERCP units 
were at the course. The survey was launched on the morning of the 
first day and was collected by the end of the day.
Study Design and Contents of the Questionnaire
The survey included 34 questions and was developed based on 
a previous questionnaire [18] as well as on the current ESGE guide-
lines concerning papillary cannulation and sphincterotomy tech-
niques at ERCP [7] and prophylaxis of PEP [13]. The questionnaire 
(online supplementary appendix; for online suppl. material, see 
www.karger.com/doi/10.1159/000487150) was divided into four 
sections: (1) general data concerning age, years of practice, annual 
and overall volume of the endoscopist, as well as characteristics 
of the center, including main practice setting, (2) techniques of 
biliary cannulation used and rescue strategies in difficult cases, 
(3) strategies of PEP prophylaxis, and (4) using conventional pre-
cut and fistulotomy and type of training. All surveys were anony-
mous and no financial or other incentives were offered for comple-
tion of the questionnaires.
Data Collection and Analysis
The data obtained from the questionnaires were extracted and 
summarized on an electronic dedicated database. All answers were 
included for analysis when possible and blank answers (missing 
values) to individual questions were excluded from the analysis of 
that question.
Endpoints
The primary endpoints were assessment of (1) the standard 
biliary cannulation technique performed, (2) the use of precut after 
a difficult biliary cannulation, (3) the use of nonsteroidal anti-in-
flammatory drugs (NSAIDs) in PEP, and (4) the use of prophylac-
tic pancreatic stenting in pancreatic guidewire (PGW)-assisted 
biliary cannulation. The secondary endpoints included the charac-
terization of Portuguese biliary endoscopists, the overall biliary 
cannulation strategy, the type of training for precut, and the factors 
influencing the primary endpoints.
Predictors of Primary Endpoints
Five factors were evaluated as potential predictors: (1) annual 
ERCP load (categorized into two groups using 150 ERCPs/year as 
cutoff), (2) lifetime ERCPs performed (categorized into two groups 
using 2,000 ERCPs as cutoff), (3) number of years performing 
ERCP independently (categorized into two groups using 14 years 
as cutoff), (4) hospital setting (categorized into two groups: public 
hospital versus other settings), and (5) age of the endoscopist (cat-
egorized into two groups using 50 years as cutoff).
Statistical Analysis
Categorical data are shown as percentages and quantitative 
data as means and standard deviations. The potential factors as-
sociated with primary endpoints were assessed using univariate 
analysis. The univariate analysis was conducted using the χ2 test 
for categorical variables and the Student t test for continuous vari-
ables. All reported p values were for a two-tailed test, and p < 0.05 
was considered to be statistically significant. All statistical analyses 
were performed using the Stata software package version 14 (Stata-
Corp, College Station, TX, USA).
Results
Study Participants
The surveys were distributed to all individuals attend-
ing the meeting on the first day. The meeting’s audience 
included not only pancreaticobiliary endoscopists, but 
also gastroenterologists not performing ERCP, pancre-
aticobiliary endoscopists performing ERCP in other 
countries, residents of gastroenterology, and nurses. Only 
pancreaticobiliary endoscopists performing ERCP in 
Portugal without supervision were eligible for inclusion 
in the study. Thirty-two of the 40 (80%) endoscopists per-
forming ERCP without supervision in Portugal were reg-
istered at the meeting. Completed surveys were collected 
from 28 of them (response rate 87.5%). These 28 endos-
copists had performed at least 4,520 ERCPs in 2016, and 
on the whole had carried out more than 95,700 ERCPs 
during their career. The mean age was 50.4 years (stan-
dard deviation 9.59), and 89% were males (Table 1). The 
main practice setting was most often a public hospital 
(69%); 57.1% of the endoscopists had performed > 150 
ERCPs per year in the last 2 years, and 64.3% of the en-
doscopists had performed > 2,000 ERCPs throughout 
their career.
Biliary Cannulation Strategy
In patients with normal anatomy, biliary cannulation 
was performed using a guidewire access technique by 20 
endoscopists (76.9%), most often with a sphincterotome 
(n = 18, 69.2%) (Table 2). In patients with a periampul-
lary diverticulum (justadiverticular and/or intradivertic-
ular) this was also the preferred approach, used by 21 
(80.7%) and 23 (82.1%), respectively. A cannula, as the 
initial accessory elected, was used by a small minority of 
the surveyed endoscopists.
When the biliary cannulation was unsuccessful, pre- 
cut was used by 19 endoscopists (73.1%) to achieve biliary 
access as long as the patients had a normal anatomy (Ta-
ble 3). The next most common rescue technique among 
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patients with normal anatomy was PGW-assisted biliary 
cannulation for 6 endoscopists (23.1%). When a patient 
had an intradiverticular papilla, the proportion of endos-
copists using precut decreased to 37.5% (n = 9). Only 
8.3% of the endoscopists claimed to suspend ERCP after 
an initial failed biliary cannulation, and only in the sub-
group of patients with an intradiverticular papilla.
Practice of PEP Prophylaxis
Although 15 endoscopists (53.6%) used NSAIDs in all 
ERCPs (Table 4), there were 8 endoscopists (17.8%) who 
used NSAIDs in < 25% of the ERCPs performed. Among 
the 13 endoscopists who did not use NSAIDs in every 
ERCP, the following reasons were given: 6 (50%) used 
NSAIDs but only for PEP in high-risk patients, 2 (16.7%) 
were not convinced about its protective role against PEP, 
and 2 (16.7%) attempted a pancreatic stent insertion 
when NSAIDs was not used. When a PGW-assisted bili-
ary cannulation was performed, only 7 endoscopists 
(26.9%) reported to always attempt pancreatic stenting; 
46.2% of the endoscopists reported attempting prophy-
lactic pancreatic stenting in < 50% of the ERCPs using a 
PGW-assisted biliary technique. When precut was used, 
pancreatic stents for PEP were inserted in < 25% of the 
procedures by 11 endoscopists (40.7%). There were 7 en-
doscopists (25.9%) who used pancreatic stents in > 75% of 
the occasions.
Precut and Training
The rate of precut use after an initial failure to cannu-
late ranges from none to up to 20% of all cannulations. 
Two endoscopists (7.7%) reported to never have used 
precut in the previous 2 years, whereas 6 (23.1%) report-
ed a precut rate between 16 and 20% over all ERCPs per-
formed in naïve papilla (Table 5). The needle knife was 
the most common accessory used, reported by 89.3% of 
the endoscopists (n = 25), followed by a traction papillo-
tome (7.1%). Regarding the type of precut performed, 
conventional precut and fistulotomy were the most com-
mon, used by 13 endoscopists each (46.4%). Precut had 
been learned during a formal training period by 9 endos-
copists (40.9%). Thirteen endoscopists (60.1%) had be-
gun performing precut by themselves, unsupervised, 
without any previous formal hands-on training.
NSAIDs for PEP
We performed a univariate analysis to assess factors 
associated with the use of NSAIDs for PEP (Table 6). The 
proportion of ERCPs in which NSAIDs were used for 
PEP was categorized into two groups: use of NSAIDs in 
Table 1. Demographic and ERCP profile of the 28 survey respon-
dents
Male sex 25 (89%)
Age, years 50.4±9.59
Years in gastroenterology practice 17.81±8.77
Years in ERCP practice 16.42±8.30
Lifetime ERCPs performed
≤500 2 (7.1%)
501–1,000 3 (10.7%)
1,001–2,000 5 (17.9%)
2,001–4,000 6 (21.4%)
>4,000 12 (42.9%)
ERCPs performed per year
≤50 2 (7.1%)
51–100 1 (3.6%)
101–150 9 (32.1%)
151–200 3 (10.7%)
201–250 8 (28.6%)
251–300 1 (3.6%)
>300 4 (14.3%)
ERCPs performed on an ambulatory basis
≤20% 16 (64%)
21–40% 5 (20%)
41–60% 0
61–80% 4 (16%)
81–100% 0
Nonresponders 3
Main practice setting
Public hospital 18 (69.2%)
Private hospital 4 (15.4%)
Public hospital/private hospital 4 (15.4%)
Nonresponders 2
Values are presented as n (%) or mean ± standard deviation. 
ERCP, endoscopic retrograde cholangiopancreatography.
Table 2. Standard cannulation technique
Normal 
anatomy
Justadiver - 
ticular papilla
Intradiver -
ticular papilla
Guidewire-assisted 20 (76.9%) 21 (80.7%) 23 (82.1%)
Sphincterotome 18 (69.2%) 20 (76.9%) 20 (71.4%)
Cannula 2 (7.7%) 1 (3.8%) 3 (10.7%)
Contrast-assisted 6 (23%) 5 (19.2%) 5 (17.9%)
Sphincterotome 5 (19.2%) 4 (15.4%) 4 (14.3%)
Cannula 1 (3.8%) 1 (3.8%) 1 (3.6%)
Nonresponders 2 2 0
Values are presented as n (%).
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≥75% of the ERCPs versus use of NSAIDs in < 75% of the 
procedures. There was an association between the annual 
load of ERCPs performed and the use of NSAIDs. High-
volume endoscopists used NSAIDs less often (50% of 
the ERCPs) than low-volume endoscopists (83.3% of the 
ERCPs) (p = 0.049). There were no significant differences 
with the other factors evaluated.
Stents and PGW-Assisted Biliary Cannulation
The proportion of PGW-assisted biliary cannulations 
in which pancreatic stenting was attempted was divided 
in two groups: use of pancreatic stents in ≥50% of the 
ERCPs versus use of pancreatic stents in < 50% of the pro-
cedures. Low-volume endoscopists insert a pancreatic 
stent after PGW-assisted biliary cannulation more often 
(100%) compared with high-volume endoscopists, who 
only used pancreatic stents in 40% of the ERCPs (p = 0.01) 
(Table 6). There were no significant differences with the 
other factors evaluated.
Precut after Failed Biliary Cannulation
We performed univariate analysis to assess factors as-
sociated with the use of precut as the first choice after 
failed biliary cannulation in patients with normal anato-
my (Table 6). Endoscopists who had performed > 2,000 
ERCPs during their career used precut more often (87.5%) 
than endoscopists who had performed less ERCPs (50%) 
(p = 0.036). There were no significant differences with the 
other factors evaluated.
Discussion
This is the first survey performed in Portugal among 
pancreaticobiliary endoscopists on biliary cannulation 
strategies and PEP prophylaxis. In addition, this study 
provides a valuable and representative insight into the 
current ERCP practice in Portugal, as we collected data 
from a very large sample of Portuguese pancreaticobiliary 
endoscopists. As we mentioned before, we had 80% of 
them registered at our meeting, and the survey was com-
pleted by 87.5%. Overall, our sample represents 70% of all 
pancreatobiliary endoscopists working in Portugal be-
cause the current number of credentialed biliary endos-
copists who perform ERCP in an autonomous environ-
ment in our country is 40. In addition, in terms of an-
nual volume of ERCPs performed, the endoscopists in 
our sample accounted for > 90% of the total ERCPs in Por-
tugal in 2015–2016, whose estimated number in the 
above-mentioned period was 5,000; furthermore, this in-
cludes the most experienced endoscopists, since > 50% of 
them performed > 2,000 ERCPs during their careers. In 
conclusion, this is a highly representative sample that al-
lows us to characterize the ERCP practice in Portugal in 
a way it has never been done until today.
As mentioned above, the main purpose of this study 
was to assess the ERCP practice of pancreaticobiliary en-
doscopists working in Portugal, especially in two key di-
mensions – biliary cannulation and PEP prophylaxis – 
using as a benchmark the recently published ESGE guide-
lines [7, 13]. The most obvious, and probably most 
Table 3. Strategy followed in a difficult biliary cannulation
Normal 
anatomy
Justadiverticular 
papilla
Intradiverticular 
papilla
Precut 19 (73.1%) 16 (64%) 9 (37.5%)
Other strategy 7 (26.9%) 9 (36%) 15 (62.5%)
PGW-assisted biliary cannulation 6 (23.1%) 8 (32%) 7 (29.2%)
Stop the ERCP – – 2 (8.3%)
Call for a different endoscopist 1 (3.8%) 1 (4%) 1 (4.2%)
Percutaneous transhepatic cholangiography – – 1 (4.2%)
Endoscopic ultrasound-guided biliary access – – 1 (4.2%)
Other strategy – – 3 (12.5%)
Nonresponders 2 3 4
Values are presented as n (%). ERCP, endoscopic retrograde cholangiopancreatography; PGW, pancreatic 
guidewire.
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important, conclusion that we can immediately draw is 
the significant gap between evidence-based guidelines 
and routine clinical practice, especially in PEP preven-
tion. As an example, despite the ESGE guidelines’ recom-
mendations for routine administration of NSAIDs, we 
observed, on the contrary, that a large proportion of en-
doscopists do not systematically use these drugs. Another 
example of this variation is the low (about one-fourth) 
rate of attempted stent placements in PGW-assisted bili-
ary cannulation when the guidelines recommend routine 
placement.
This apparent discrepancy between evidence-based 
guidelines and current clinical practice is not unique to 
this study, as other research studies evaluating the imple-
mentation of guidelines also present similar conclusion. 
In a national survey of Dutch gastroenterologists evaluat-
ing the practice of early ERCP in the setting of acute bili-
ary pancreatitis, it was shown that indications and timing 
of ERCP are not in line with the Dutch guidelines on this 
topic [19]. A UK survey (June 2012), following the publi-
cation of the ESGE’s recommendations for routine use of 
NSAIDs for PEP prevention, found that only 35% of en-
doscopists complied with the recommendation [16, 20]. 
These results highlight the importance of increasing the 
awareness of the recommendations among Portuguese 
pancreaticobiliary endoscopists, but also the need to in-
crease the strength of the recommendations with addi-
tional randomized trials as well as incorporating the var-
ious perspectives of current clinical practice.
The initial strategy used by most Portuguese endosco-
pists for biliary cannulation is a guidewire-assisted tech-
nique, usually with a sphincterotome. Nonetheless, there 
is a small minority that opts for contrast-assisted cannu-
lation, despite the recommendation for a guidewire-as-
sisted technique, as it reduces the risk of PEP. The guide-
wire-assisted cannulation, although currently favored in 
Western countries, is not the first choice in some Eastern 
countries, such as Japan. In Japan, a study evaluating bil-
Table 5. Precut practice and training
Proportion of ERCPs (naïve papilla) with precut attempt
0% 2 (7.7%)
<5% 6 (23.1%)
6–10% 10 (38.5%)
11–15% 2 (7.7%)
16–20% 6 (23.1%)
Nonresponders 2
Precut device
Needle knife 25 (89.3%)
Erlangen papillotome 2 (7.1%)
Other 1 (3.6%)
Precut technique
Conventional precut 13 (46.4%)
Fistulotomy 13 (46.4%)
Other 2 (7.1%)
Precut training
Observation as a trainee 6 (27.2%)
Formal training during residency 9 (40.9%)
No previous training, initial precut not supervised 7 (31.8%)
Nonresponders 4
Not applicable 2
Values are presented as n (%). ERCPs, endoscopic retrograde 
cholangiopancreatographies.
Table 4. PEP prophylaxis
ERCPs with NSAIDs PEP prophylaxis
0% 2 (7.1%)
<25% 3 (10.7%)
25–50% 3 (10.7%)
51–75% 2 (7.1%)
76–99% 3 (10.7%)
100% 15 (53.6%)
Reason to not always administer NSAIDs for PEP prophylaxis
NSAIDs administered only in high–risk patients 6 (50%)
Not convinced about the role of NSAIDs in PEP 
prophylaxis 2 (16.7%)
Use pancreatic stents 2 (16.7%)
Other reason 2 (16.7%)
Not applicable 15
Nonresponder 1
PGW with attempt at pancreatic stenting
0% 2 (7.7%)
<25% 6 (23.1%)
25–50% 4 (15.4%)
51–75% 6 (23.1%)
76–99% 4 (15.4%)
100% 7 (26.9%)
Nonresponders 2
Precuts with attempt at pancreatic stenting
0% 4 (14.8%)
<25% 7 (25.9%)
25–50% 6 (22.2%)
51–75% 3 (11.1%)
76–99% 5 (18.5%)
100% 2 (7.4%)
Nonresponder 1
Values are presented as n (%). ERCPs, endoscopic retrograde 
cholangiopancreatographies; NSAIDs, nonsteroidal anti-inflam-
matory drugs; PEP, post-endoscopic retrograde cholangiopancre-
atography pancreatitis; PGW, pancreatic guidewire.
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iary cannulation trends showed that contrast-assisted 
cannulation is still used as the first choice in most high-
volume centers [21].
After a failed biliary cannulation, the preferred initial 
salvage choice is precut (73.1%), followed by PGW-assist-
ed cannulation (23.1%). The ESGE recommends both, 
giving preference to PGW in the case of multiple unin-
tentional pancreatic duct cannulation. In our research, 
there was an association between ERCP experience and 
use of precut as the first choice after an unsuccessful can-
nulation. Among experienced endoscopists, 87.5% per-
formed precut as the first option after unsuccessful can-
nulation; only 50% of less experienced endoscopists chose 
precut as the initial rescue technique. Precut is an ad-
vanced ERCP technique which significantly depends on 
the endoscopist’s skills [22, 23]. Although it is very safe 
and highly successful in the hands of skilled endoscopists, 
it is dangerous when performed by less experienced en-
doscopists [24, 25]. In a recent European survey, this was 
the first choice followed by 42 and 100% of the endosco-
pists, depending on whether the main pancreatic duct 
was cannulated or not, respectively [25, 26]. The high 
proportion of Portuguese endoscopists who chose precut 
may be associated with the high number of experienced 
endoscopists represented in our sample.
Regarding the routine administration of rectal NSAIDs 
for PEP prevention, the self-reported proportion of 
endoscopists who followed this recommendation was 
53.6%. There were 10.7% who had never used NSAIDs. 
Among the endoscopists who did not routinely use 
NSAIDs, 2 reported that they were not convinced of their 
protective role. There was an inverse association between 
the annual volume of ERCPs by endoscopist and compli-
ance with this recommendation. High-volume endosco-
pists tend to use NSAIDs less frequently than low-volume 
endoscopists. This observation is puzzling and may be 
related to the idea that guidelines do not apply to endos-
copists who already have low rate of post-ERCP adverse 
events [27]. In fact, there was no randomized control tri-
al in which the protective role of NSAIDs was evaluated 
in centers with low incidence of adverse events. However, 
given the strength of the recommendations, their safety, 
and their ease of implementation (especially NSAIDs), we 
believe that they should be followed by all endoscopists, 
Table 6. Determinants of NSAIDs use, stents in PGW-assisted cannulation, and precut choice
NSAIDs for PEP in 
≥75% of patients 
Stent use in PGW-assisted 
cannulation in >50% of 
ERCPs
Precut as first choice 
after failed cannulation
% p % p % p
ERCP load 0.049* 0.01* 0.117
>150/year 50 40 85.7
≤150/year 83.3 100 58.3
Lifetime ERCP volume 0.638 0.067 0.036*
>2,000 61.1 52.9 87.5
≤2,000 70 88.9 50
ERCP independently 0.611 0.484 0.079
>14 years 69.2 58.3 90.9
≤14 years 60 71.4 60
Hospital setting 0.492 0.751 0.492
Public hospital 61.1 68.8 61.1
Other 75 75 75
Age 0.345 0.891 0.795
>50 years 71.4 69.2 72.2
≤50 years 53.8 66.7 66.7
ERCP, endoscopic retrograde cholangiopancreatography; NSAIDs, nonsteroidal anti-inflammatory drugs; 
PEP, post-endoscopic retrograde cholangiopancreatography pancreatitis; PGW, pancreatic guidewire. * Statisti-
cally significant (p < 0.05).
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including experts, regardless of the incidence of adverse 
events in their own practice. These wide variations in 
clinical practices between endoscopists reinforce the im-
portance to establish the routine collection and analysis 
of quality indicators, preferably on a national basis, in or-
der to assure the safety of the patients and increase the 
quality of care.
Although the ESGE recommends attempting pancre-
atic stenting in all patients with PGW-assisted biliary can-
nulation, this guideline was followed by only 26.9% of our 
sample. High-volume endoscopists attempted to deliver 
pancreatic stents less frequently than low-volume endos-
copists. Several reasons could explain the low rate of pan-
creatic stents observed in our survey. First, since this tech-
nique is performed after a difficult biliary cannulation, if 
the pancreatic stent is not inserted before biliary cannula-
tion, there is a natural tendency to proceed rapidly with 
the ERCP and perform the necessary therapeutic proce-
dures once the common bile duct is successfully cannu-
lated, removing the pancreatic wire (as it may interfere 
with the therapeutic maneuvers). Secondly, if stenting is 
performed at the end of the procedure, the procedure, 
which already has a long duration, will be extended, since 
it is necessary to cannulate the main pancreatic duct once 
again. In addition, there is a small possibility of not insert-
ing a pancreatic stent, which is per se associated with an 
increase in the PEP rate [28]. A study involving 146 pa-
tients in whom pancreatic stenting was attempted after 
PGW-assisted cannulation reported an unsuccessful rate 
of 14%; the rate of pancreatitis was 4.2% in the stent group 
versus 29% in the group in which it was not possible to 
insert a stent [29].
The use of precut varies between endoscopists from 
nonexistent (2 endoscopists) to 20%. Although most of 
the endoscopists reported a rate of use < 10%, there was a 
group of 23.1% who report a use rate between 16 and 20%. 
The variability on this indicator is comparable to the 
trend reported in other studies, resulting from personal 
preferences and policies of the centers about precut [25, 
30, 31]. Regarding the most frequently used techniques, 
conventional precut (46.4%) and fistulotomy (46.4%) 
were the two most common precut techniques used by 
Portuguese endoscopists, with only 2 endoscopists re-
porting using another variant. Despite the recommenda-
tions and the recent evidence pointing to fistulotomy as 
the precut technique of choice, since it decreases the risk 
of PEP as well as the overall duration of ERCP especially 
if performed early in the cannulation algorithm, there 
were 13 endoscopists (46.4%) who opted for convention-
al precut [27, 32]. This observation can be explained in 
part by the fact that conventional precut was perceived as 
easier to learn and perform as well as less dangerous when 
compared to fistulotomy. Even with recent evidence fa-
voring fistulotomy, there may be a natural resistance to 
switching from one technique we master to another. The 
tendency to keep the same type of precut over time has 
already been described by others [31, 33]. Regarding pre-
cut training, only 40.9% received a formal hands-on 
training during their residency. All the others began to 
perform precut in their hospitals without any specific su-
pervision or previous hands-on training. This observa-
tion is in line with the few articles published on precut 
learning curve: a large percentage of endoscopists started 
to perform precut without previous training [22, 34]. As 
the focus of ERCP should be on quality, and assuming 
that precut should be an obligatory part of the armamen-
tarium of every new pancreaticobiliary endoscopist, it 
should be a mandatory issue in the ERCP training cur-
riculum for all future interventional endoscopists. The 
quality of precut in Portugal should be addressed in fu-
ture studies.
The main limitation of this study is related to the fact 
that data were collected through a survey. Surveys have 
several limitations, as previously described, especially se-
lection and recall bias. The selection bias was partially 
overcome in our study, as we were able to get a sample 
representing 70% of the country’s pancreaticobiliary en-
doscopists. As our sample is responsible for > 90% of all 
ERCPs performed in Portugal, it may have skewness for 
more experienced endoscopists. Despite all this, these 
surveys are excellent tools to get valuable insights into 
multiple dimensions of healthcare. The alternative, i.e., 
the performance of an audit, although more complete and 
reliable, presents several challenges related to costs, bu-
reaucracy, operational complexity, and duration. In our 
opinion they are two complementary tools that should be 
used in sequence depending on the question to be as-
sessed.
The diverse ERCP practices observed in our survey 
highlight the need to promote an in-depth discussion 
among Portuguese pancreatobiliary endoscopists. ERCP 
advanced endoscopy meetings, such as the one held in 
Portugal in 2016, could be the perfect occasion to discuss 
this and other topics, as most Portuguese endoscopists 
performing ERCP would be present. Furthermore, other 
ERCP research projects could be fostered, ranging from 
insights into other practice dimensions, such as the use of 
intensive hydration in the periprocedural period with in-
travenous lactated Ringer solution to validation studies 
[35].
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Conclusions
There is a pronounced discrepancy between evidence-
based guidelines and current clinical practice. This dis-
crepancy is more pronounced in PEP prophylaxis, espe-
cially among high-volume endoscopists. Some advanced 
techniques in ERCP, such as precut, are initiated unsu-
pervised, without any previous formal training. Precut 
and other advanced ERCP-related techniques should be 
an obligatory issue in the ERCP training curriculum for 
all future interventional endoscopists. We strongly sug-
gest that the Portuguese Society of Endoscopy initiate a 
large debate on the training and credentialing of ERCP in 
Portugal.
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